Does Tirzepatide's Benefits in Patients with Type 2 Diabetes Make The Price Worth It?April 12th 2023
Tirzepatide was associated with a greater reduction in hemoglobin A1c and body weight when compared to semaglutide. But with a current list price of $1,023 for a one-month supply, is tirzepatide (Mounjaro; Lilly) worth it?
Half of All Meningococcal Vaccination Appointments Were Delayed or Canceled During COVID-19 PandemicApril 6th 2023
Data reveal 50% of meningitis vaccination appointments were delayed or canceled amid the COVID-19 pandemic, leading authors of a survey to highlight the need for “urgent action” to maintain routine vaccination levels among children.